Adrian Rawcliffe, Adaptimmune
James Noble is taking his last lap at the biotech he founded, and saved. It's Adrian Rawcliffe's turn now
Back in the summer of 2014, Adaptimmune CEO James Noble had about a million pounds in the bank. Not too much to survive on, as …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
